Herzlich Willkommen!
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D. Our findings are illustrated not only in cases of Swiss pharmaceutical industry, but also by industry cases from the US and Asia.
Autor: Gassmann, Oliver Reepmeyer, Gerrit von Zedtwitz, Maximilian
ISBN: 9783540776352
Auflage: 2
Sprache: Englisch
Seitenzahl: 186
Produktart: Gebunden
Verlag: Springer Berlin
Veröffentlicht: 03.03.2008
Untertitel: Trends and Drivers for Growth in the Pharmaceutical Industry
Schlagworte: Drug Discovery Forschung & Entwicklung Globalization Innovation Management Pharmaceuticals Productivity R&D Management business development innovation

0 von 0 Bewertungen

Durchschnittliche Bewertung von 0 von 5 Sternen

Bewerten Sie dieses Produkt!

Teilen Sie Ihre Erfahrungen mit anderen Kunden.